Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis

Clinical trial NCT00453401 · COMPLETED

Trial details

NCT number: NCT00453401
Sponsor: NanoBio Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Herpes Labialis

Start date: 2007-02-01
Primary completion: 2007-12-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.